---
title: "Cortigent, Inc. (CRGT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRGT.US.md"
symbol: "CRGT.US"
name: "Cortigent, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T09:03:29.073Z"
locales:
  - [en](https://longbridge.com/en/quote/CRGT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRGT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRGT.US.md)
---

# Cortigent, Inc. (CRGT.US)

## Company Overview

Cortigent, Inc. develops and sells precision neurostimulation systems to help patients recover critical body functions. It is developing Orion, a visual cortical prosthesis system for individuals who are blind due to a various cause, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury, as well as to improve recovery of arm and hand function in partially paralyzed stroke patients who are undergoing rehabilitation after stroke. The company was founded in 1998 and is based in Valencia, California.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CRGT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CRGT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CRGT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CRGT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**